Alan Fuhrman Spring Works Therapeutics, Inc. (SWTX) insider trading activity

SWTX Quotes by TradingView

Alan Fuhrman is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 14,667 shares of SWTX, which is worth approximately $549,132. The most recent transaction as insider was on May 16, 2024, when has been sold 4,095 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.7K
0% 3M change
38.73% 12M change
Total Value Held $549,132

Alan Fuhrman Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
BUY
Grant, award, or other acquisition
-
4,095 Added 21.83%
14,667 Common Stock
May 24 2023
BUY
Grant, award, or other acquisition
-
4,648 Added 30.54%
10,572 Common Stock
May 19 2022
BUY
Grant, award, or other acquisition
-
4,818 Added 44.85%
5,924 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
-
1,106 Added 4.2%
25,227 Common Stock

Also insider at

ESPR
Esperion Therapeutics, Inc. Healthcare
Director
CMPI
Checkmate Pharmaceuticals, Inc.
Director
TYRA
Tyra Biosciences, Inc. Healthcare
Chief Financial Officer
AF

Alan Fuhrman

Director
Stamford, CT

Track Institutional and Insider Activities on SWTX

Follow SpringWorks Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

News

Receive news related to SpringWorks Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SWTX